Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18.5M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
-281K
-
Total reported value, excl. options
-
$194M
-
Value change
-
-$6.84M
-
Put/Call ratio
-
0.24
-
Number of buys
-
51
-
Number of sells
-
-73
-
Price
-
$14.63
Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q1 2023
151 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q1 2023.
OptimizeRx Corp - Common Stock (OPRX) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 18.5M outstanding shares and own 71.69% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.04M shares), First Light Asset Management, LLC (1.01M shares), VANGUARD GROUP INC (868K shares), BLAIR WILLIAM & CO/IL (843K shares), G2 Investment Partners Management LLC (536K shares), Casdin Capital, LLC (500K shares), Point72 Asset Management, L.P. (476K shares), D. E. Shaw & Co., Inc. (471K shares), WASATCH ADVISORS LP (469K shares), and STATE STREET CORP (423K shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.